Tradestie Institutional Equity Comparison Engine
NDRA vs NEO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NEO Overall Edge
NEO Captures Institutional Edge (3โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NeoGenomics, Inc. (NEO) driven by superior Valuation, Momentum & Technical, Options & Structure while NDRA counters with relative strength in Growth & Margin. Fundamentally, NDRA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NEO at N/M Forward P/E and -5.5% operating margin (+11.4% YoY). In options structure, NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NEO sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NEO
NDRA N/M vs NEO N/M Fwd P/E
Growth & Margin Winner
NDRA
Op Margin 0.0% vs -5.5% ยท YoY +0.0% vs +11.4%
Momentum & Technical Winner
NEO
1Y -32.7% vs +49.9% ยท 52W Pos 37% vs 64%
Options & Structure Winner
NEO
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (14th %ile IV)
NDRA
NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap
$6.6M
1M Return
-6.75%
1Y Return
-32.72%
Forward P/E
N/M
Unified AI Score
44.7 / 100
HOLD
Tech 35.0
Fund 46.0
Flow 50.0
Mom 60.0
NEO
NASDAQ
NeoGenomics, Inc.
Services-Testing Laboratories
$15.49
+0.55% 1D
Market Cap
$2.1B
1M Return
-5.63%
1Y Return
+49.85%
Forward P/E
N/M
Unified AI Score
35.6 / 100
SELL
Tech 23.0
Fund 44.0
Flow 58.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NDRA -32.72%
NEO +49.85%
Spread: +83.06 pp (NEO Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NDRA Revenue | NEO Revenue | NDRA Op. Margin | NEO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $280M | -146080.5% | 3.6% | NEO |
| FY2019 | N/A | $410M | N/A | 3.2% | NEO |
| FY2020 | N/A | $440M | N/A | -3.1% | NEO |
| FY2021 | N/A | $480M | N/A | -24.5% | NEO |
| FY2022 | N/A | $510M | N/A | -30.9% | NEO |
| FY2023 | N/A | $590M | N/A | -18.2% | NEO |
| FY2024 | N/A | $660M | N/A | -13.9% | NEO |
| FY2025 | N/A | $730M | N/A | -15.9% | NEO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NDRA | NEO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.6M | $2.1B | Larger Scale | NEO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +11.4% | Higher Growth | NEO |
| Operating Margin (TTM) Profitability | 0.0% | -5.5% | Higher Margin | NDRA |
| Net Profit Margin Profitability | 0.0% | -4.1% | Higher Margin | NDRA |
| Return on Equity (ROE) Capital Efficiency | -152.0% | -3.9% | Higher ROE | NEO |
| 52-Week Range Position Momentum | 37% ($3โ$7) | 64% ($7โ$20) | Stronger Trend | NEO |
| Beta / 30D Volatility Risk Regime | 0.71ฮฒ ยท 48% Vol | 1.23ฮฒ ยท 47% Vol | Lower Realized Risk | NEO |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 35.6 / 100 (SELL) | Higher Composite | NDRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NDRA vs NEO Buy Guide
NDRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NEO
CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
14th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NDRA nor NEO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.